fda approval for semaglutide 🎉Exciting news that is now approved MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% What's New in Obesity Treatment?

Rather, any association appears to be indirect, mediated through alterations in bowel habits

This makes it a critical subject of study for cases where traditional incretin therapies have reached a plateau or where hepatic steatosis is a primary concern

This distinction is a requirement for the labels of research chemicals, exempting them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR)

I understand those worries

Food and Drug Administration on Friday announced the approval of pharmaceutical giant Novo Nordisk's Wegovy (semaglutide) injection for adults who either have obesity or are overweight and have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

Semaglutide activates these receptors, which may reduce neuroinflammation and stabilize neuronal firing patterns associated with migraine onset